Table 9. Adverse effects after obinutuzumab-bendamustine therapy until the end of the observation period.
| CLL | FL | |
|---|---|---|
| Neuroborreliosis | 1 (12,5) | 0 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.